CD22 Redirected Autologous T Cells for ALL
Clinical trial NCT02650414 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02650414
- Sponsor
- University of Pennsylvania
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-13
- Primary completion
- 2037-12-01
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.